The federal cases against Pfizer and generic drug manufacturers of generic Depo Provera have been consolidated in the northern district of Florida. Kansas City Depo Provera Lawyer Jeffrey Carey has extensive experience with defective and dangerous drug and product litigation.
If you have developed intracranial meningiomas after taking Depo Provera you have a claim for damages against Pfizer. A MDL stands for multi-district litigation. The initial phases of the case will be handled by the judge in northern Florida. Then, presuming cases survive inevitable motions to dismiss or for summary judgment, there is typically a settlement offer to the members of the MDL class. Importantly, if you do not want to take what is offered at that time you can proceed with your case and it will be transferred to your home jurisdiction. For Kansas City area victims of brain tumors caused by Depo Provera use, their case would ordinarily be heard in the Western District of Missouri or District of Kansas federal courts.
It is early in the process and litigation but it appears that Pfizer has known for a significant period of time that the risk of developing meningiomas is increased substantially by exposure to Depo Provera. Jeffrey Carey is investigating the knowledge that Pfizer may have gained from the nearly three decade period when the drug was being used and tested extensively in the developing world. Victims deserve to know when Pfizer knew or should have known about the risk. The revelations occurred through a British Journal of Medicine bombshell report on the connection in the spring of 2024. Depo Prover, however, had been used extensively worldwide for sixty years at that point. What did Pfizer and Uphohn know and when did they know it?
Lawsuits against Pfizer for meningioma developing after long term depo provera use will typically involve claims for failure-to-warn, defective design, negligence, misrepresentation, and breach of warranty. As injectables, the warnings would typically have been given by a “learned intermediary” such as the treating physician. Many women, however, self-injected and would have also relied on drug inserts. The center of these cases is the belief that Pfizer knew about the enhanced risk of brain tumors caused by its drugs and hid that information from the public to preserve profits.
Depo Provera was a famously difficult approval process when it first occurred. As far back as 1988, after a 20 year approval process, the FDA warned that the drug was causing cancer in testing animals according to a publication by the National Institute of Health.
This litigation is moving fast and we will be updating (as can be done under the Court’s protective order) as the process proceeds.
If you or a loved one have developed meningioma after taking Depo Provera, Jeff Carey can help. Call 816-246-9445 to schedule a free no-obligation consultation.